Posts associated with liquid biopsy
Stabilization

FDA clearance brings liquid biopsy into a new era

With the FDA clearance of several assays, liquid biopsy moves closer toward the goal of making this screening method a standard of care. Liquid biopsy…
Read More
Stabilization

How can nucleic acids predict disease?

Liquid biopsy is a diagnostic technique where bodily fluids are examined for biomarkers that suggest disease. In recent years, liquid biopsy has been …
Read More
Why stabilization matters
Stabilization

Why does stabilization matter?

Human blood is packed with genetic information found in circulating cell-free DNA (cfDNA) and cell-free RNA (RNA). Liquid biopsy takes advantage of th…
Read More
Sequencing DNA
Stabilization

FDA drafts guidance on ctDNA

Earlier this year, the U.S. Food and Drug Administration released a draft guidance regarding the use of circulating tumor DNA (ctDNA) for early-stage …
Read More
Stabilization

Cleared assays advance liquid biopsy

The goal of liquid biopsy moved closer to reality in past weeks. Liquid biopsy is the use of a bodily fluid to collect information from a distant site…
Read More
Stabilization

Circulating RNA and EV poster

Streck recently presented data on our new and innovative blood collection tube, RNA Complete BCT™, at the American Association for Cancer Resea…
Read More
Stabilization

New tube maintains EVs and cfRNA

Streck R&D Senior Scientific Manager Nick George, Ph.D., recently presented a 15-minute talk titled “Introducing RNA Complete BCT® (RUO), a nov…
Read More
Stabilization

Key development for liquid biopsy research

A recent publication from the BloodPAC group seeks to standardize pre-analytical variables for liquid biopsies. Titled “Minimum Technical Data Eleme…
Read More
Stabilization

Clear advantage of glass BCTs

When choosing between glass or plastic blood collection tubes designed to maintain the cell-free DNA population, there is an often overlooked aspect w…
Read More